What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His primary areas of study are Amyloidosis, AL amyloidosis, Internal medicine, Cardiac amyloidosis and Pathology.
His research integrates issues of Incidence, Transthyretin and Primary systemic amyloidosis, Serum amyloid P component, Amyloid in his study of Amyloidosis.
His AL amyloidosis study combines topics in areas such as Surgery, Chemotherapy, Transplantation, Young adult and Multiple myeloma.
His Internal medicine research integrates issues from Gastroenterology, Endocrinology and Cardiology.
His research in the fields of Amyloid cardiomyopathy overlaps with other disciplines such as Human genome.
His studies in Pathology integrate themes in fields like Serum amyloid A, Immunofixation and Glomerulopathy.
His most cited work include:
- Natural history and outcome in systemic AA amyloidosis. (649 citations)
- Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. (608 citations)
- Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. (519 citations)
What are the main themes of his work throughout his whole career to date?
Julian D. Gillmore mainly focuses on Amyloidosis, Internal medicine, AL amyloidosis, Pathology and Transthyretin.
His specific area of interest is Amyloidosis, where he studies Cardiac amyloidosis.
Julian D. Gillmore focuses mostly in the field of Internal medicine, narrowing it down to matters related to Gastroenterology and, in some cases, Lenalidomide.
As part of one scientific family, Julian D. Gillmore deals mainly with the area of AL amyloidosis, narrowing it down to issues related to the Surgery, and often Cohort and Primary systemic amyloidosis.
The Pathology study combines topics in areas such as Immunoglobulin light chain and Kidney.
His studies deal with areas such as Fibrillogenesis, Polyneuropathy and Scintigraphy as well as Transthyretin.
He most often published in these fields:
- Amyloidosis (61.02%)
- Internal medicine (49.64%)
- AL amyloidosis (42.62%)
What were the highlights of his more recent work (between 2018-2021)?
- Amyloidosis (61.02%)
- Internal medicine (49.64%)
- Transthyretin (22.28%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Amyloidosis, Internal medicine, Transthyretin, AL amyloidosis and Cardiology.
His Amyloidosis study necessitates a more in-depth grasp of Pathology.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology.
His study in Transthyretin is interdisciplinary in nature, drawing from both Dermatology, Quality of life, Scintigraphy and Intensive care medicine.
The study incorporates disciplines such as Ixazomib, Chemotherapy, Lenalidomide, Dexamethasone and AA amyloidosis in addition to AL amyloidosis.
His Cardiology research is multidisciplinary, relying on both Interquartile range and Pathophysiology.
Between 2018 and 2021, his most popular works were:
- The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. (119 citations)
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging (77 citations)
- Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis. (69 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Julian D. Gillmore mainly investigates Amyloidosis, Internal medicine, Transthyretin, Cardiac amyloidosis and Cardiology.
Amyloidosis is a subfield of Pathology that Julian D. Gillmore studies.
The concepts of his Transthyretin study are interwoven with issues in Cardiomyopathy and Quality of life.
His work carried out in the field of Cardiac amyloidosis brings together such families of science as Expert consensus, Magnetic resonance imaging, Amyloid deposition and Diastole.
His work deals with themes such as Gastroenterology, Ixazomib, Cohort and Confidence interval, which intersect with AL amyloidosis.
The various areas that Julian D. Gillmore examines in his Amyloid study include Immunohistochemistry, Fibril, Staining and Histology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
